Michael joined Nanosonics as CEO and President effective October 2013. He was a Non-executive Director of the Board from July 2012 to October 2013. Michael has more than 26 years of international commercial experience in the healthcare market, having held local, regional and global roles in medical device and pharmaceutical industries. Before joining Nanosonics he was Senior Vice President of Global Marketing for the major medical device company Cochlear Ltd, a position he held for more than 10 years.

Steven joined Nanosonics as Senior Vice President, Design and Development, in September 2016 and was appointed to the role of CTO in February 2018. He has over 21 years’ experience leading the development of medical devices. Prior to Nanosonics, Steven held a range of senior executive roles with ResMed, including VP of Technology and VP of Product Development. He is an inventor of almost 300 granted and pending patents and is an Adjunct Professor of Engineering at The University of Sydney.

Rod joined Nanosonics in April 2019. He is an international operations executive with over 20 years of experience, having held critical roles in companies such as Cochlear and GM Holden. During his 13-year tenure at Cochlear, Rod held roles such as Global Head of Manufacturing and Chair of the Operational Excellence Strategy Group. At GM Holden, Rod held senior management roles across operations and global customer support. Rod is also an award-winning academic with continuing Adjunct Faculty appointments for over 12 years with MGSM, AGSM and the University of Sydney Business School.

Matt joined Nanosonics in August 2017. He was appointed to the Executive Team in October 2021, and as Company Secretary in May 2023. Matt is responsible for all legal and corporate governance matters across the Nanosonics Group. Matt is also the executive sponsor for Sustainability activities. Prior to joining Nanosonics, Matt held a variety of senior legal roles in Australia and abroad with a focus on technology and healthcare. Immediately prior to joining Nanosonics, Matt served as General Counsel for an international software business based in London. Matt is a member of the Australian Institute of Company Directors, and the Governance Institute of Australia.

Matthew joined Nanosonics in April 2022. He has over 20 years of experience in strategic marketing and product management in medical device, high technology and consulting fields across the full product development cycle. Prior to Nanosonics, Matthew held a range of strategic executive roles including Global Director of Portfolio Strategy & Planning at Cochlear, R&D management at ResMed and Founder-CEO of an enterprise SaaS software startup.

Jodi joined Nanosonics in April 2020. Jodi is an experienced human resources professional who has contributed to strategy, culture and business transformation at an executive level in the finance, telco and IT industries. Most recently, Jodi was Head of Human Resources with the Eclipx Group. She has also led international human resource functions as HR Director for Samsung and Head of Human Resources, Asia Pacific at Orange Business Services.

Sunny joined Nanosonics as CIO in November 2022. He has more than 25 years of experience in Information Technology in diverse sectors such as medical device, telco and insurance, with a specific focus on Digital Transformation and Data Engineering platforms. Prior to Nanosonics, Sunny held senior management roles with Resmed, including Head of Finance Systems and Senior Director of Product Innovation.

Jason joined Nanosonics as CFO effective October 2023. Jason has more than 25 years of international experience across healthcare, construction, and financial services industries. Before joining Nanosonics he held senior finance roles with General Electric (GE) for 15 years, notably CFO for GE Healthcare Australia & New Zealand. More recently, he held several CFO roles with the Hilti group for over 6 years in Dubai and Singapore. Jason is a member of the Institute of Chartered Accountants Australia and New Zealand and attained executive education in Strategic Financial Analysis from Harvard Business School, USA.

Ken joined Nanosonics in September 2017 as Regional President for the United States, Canada and Latin America. He has more than 20 years’ experience in the healthcare, medical devices and consumer products industries. Most recently Ken was the President for Amoena GmbH and prior to that he held general management roles at BSN Medical, Medicom, Energizer and Pfizer.

Ronan joined Nanosonics in September 2019 and is responsible for Nanosonics’ continued expansion across Europe and the Middle East. He has more than 20 years’ experience in infection prevention through senior sales, management and business development roles with Advanced Sterilization Products and Wassenburg Medical, a global leader in endoscope reprocessing. Most recently, Ronan was the Vice President of Global Sales and a Board member at Wassenburg Medical, where he had also served as Managing Director for Ireland and Director of Business Development for EMEA.

Katsumi joined Nanosonics in April 2016 as the Acting Country Manager for Japan, playing a significant role in the establishment & growth of the Japanese business during this time. Nanosonics Japan K.K. was established in January 2019 and in September 2019, Katsumi was appointed President of Nanosonics Japan K.K. Katsumi has over 25 years experience in developing and managing businesses & investments between Australia and Japan within the lifesciences sector. He has served as a board member and held senior management roles in major international companies in both Australia and Japan.

Gareth joined Nanosonics in February 2020 to support existing business across Europe, Middle East and Africa. Gareth brings with him a wealth of specialist experience in the area of decontamination for reusable invasive medical devices. Gareth started his career with Wassenburg Medical Ireland, experts in endoscope reprocessing and infection prevention solutions before joining Cantel Medical Canada. Whilst supporting their North American expansion, he worked with procedural & infection prevention products for endoscopy and sterility products for Central Sterile Services Departments.

Ms. Klatt joined the Nanosonics team in October 2021. She has more than 20 years of national and international commercial experience in the healthcare market, having held local, regional and global roles in medical device industry. Before joining Nanosonics, she was working in several leadership and board roles in sales and marketing for companies like Medtronic, Hill-Rom, Baxter and Spacelabs. In addition, Ms. Klatt has been developing prospective executives in the context of training and coaching for many years. For her second degree in Marketing she was honored with the “German Study Award 2010”.